Catalyst Wire Dossier Catalyst Wire Dossier

Lenzilumab

lenzilumab · Humanigen, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lenzilumab, covering 2021-03-03 to 2024-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma [Phase 1]

See pricing